MERCK & CO., INC. (MRK)
Clinical trial NCT05708950 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-12-31 → 2025-12-18 3. primary completion date: 2024-06-30 → 2025-10-16 4. enrollment: 314 → 40 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical